244 related articles for article (PubMed ID: 18472407)
1. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.
Rizza S; Clementi F; Porzio O; Cardellini M; Savo A; Serino M; Chiricolo G; Romeo F; Lauro R; Federici M
Nutr Metab Cardiovasc Dis; 2009 Jan; 19(1):54-60. PubMed ID: 18472407
[TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
3. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.
Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A
J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666
[TBL] [Abstract][Full Text] [Related]
4. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
5. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
[TBL] [Abstract][Full Text] [Related]
6. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
Yaturu S; Daberry RP; Rains J; Jain S
Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
[TBL] [Abstract][Full Text] [Related]
7. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.
Graessler J; Gruber M; Radke RB; Kopprasch S; Schwarz PE; Kamke W; Bornstein SR; Fischer S
Gerontology; 2011; 57(4):316-26. PubMed ID: 20551622
[TBL] [Abstract][Full Text] [Related]
9. Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
Wykretowicz A; Guzik P; Bartkowiak G; Krauze T; Kasinowski R; Dziarmaga M; Wesseling KH; Wysocki H
Clin Sci (Lond); 2005 Oct; 109(4):397-403. PubMed ID: 15948715
[TBL] [Abstract][Full Text] [Related]
10. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
11. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis.
Saely CH; Risch L; Hoefle G; Rein P; Muendlein A; Marte T; Aczel S; Langer P; Drexel H
Clin Chim Acta; 2007 Aug; 383(1-2):97-102. PubMed ID: 17550784
[TBL] [Abstract][Full Text] [Related]
12. Glucose metabolism in non-diabetic patients with stable coronary artery disease.
Santos JF; Almeida M; Ferreira J; Gonçalves P; Raposo L; Teles R; Branco J; Catroga T; Machado FP; Silva A
Rev Port Cardiol; 2006 Jan; 25(1):39-53. PubMed ID: 16623355
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of plasma adiponectin in prediabetes, Type 2 diabetes and coronary artery disease.
Yaturu S; Bridges JF; Subba Reddy DR
Med Sci Monit; 2006 Jan; 12(1):CR17-20. PubMed ID: 16369465
[TBL] [Abstract][Full Text] [Related]
14. Total and high molecular weight adiponectin in patients with coronary artery disease.
El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
[TBL] [Abstract][Full Text] [Related]
15. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
[TBL] [Abstract][Full Text] [Related]
18. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
[TBL] [Abstract][Full Text] [Related]
19. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus.
Suchanek H; Myśliwska J; Siebert J; Wieckiewicz J; Hak Ł; Szyndler K; Kartanowicz D
Eur Cytokine Netw; 2005 Sep; 16(3):177-85. PubMed ID: 16266856
[TBL] [Abstract][Full Text] [Related]
20. Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Saydam GS; Dogan M; Ulupinar H; Aydin C; Topcu DI; Sasmaz A
Coron Artery Dis; 2008 Mar; 19(2):79-84. PubMed ID: 18300743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
